DUPONT E I DE NEMOURS & CO | 2013 | FY | 3

GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill
The following table summarizes changes in the carrying amount of goodwill for the years ended December 31, 2013 and 2012, by reportable segment:
 
Balance as of December 31, 2013
Goodwill
Adjustments
and
Acquisitions
Balance as of December 31, 2012
Goodwill
Adjustments
and
Acquisitions
Balance as of December 31, 2011
Agriculture
$
330

$
99

$
231

$
(1
)
$
232

Electronics & Communications
149

—

149

—

149

Industrial Biosciences
898

8

890

24

866

Nutrition & Health
2,315

1

2,314

(8
)
2,322

Performance Chemicals
185

—

185

—

185

Performance Coatings
—

—

—

(809
)
809

Performance Materials
388

(13
)
401

(3
)
404

Safety & Protection
448

2

446

—

446

Total
$
4,713

$
97

$
4,616

$
(797
)
$
5,413



Changes in goodwill in 2013 primarily relate to goodwill associated with an acquisition in the Agriculture segment. Changes in goodwill in 2012 primarily relate to goodwill associated with the Performance Coatings business that was reclassified as held for sale (see Note 2). In 2013 and 2012, the company performed impairment tests for goodwill and determined that no goodwill impairments existed.

Other Intangible Assets
The following table summarizes the gross carrying amounts and accumulated amortization of other intangible assets by major class:
 
December 31, 2013
December 31, 2012
 
Gross
Accumulated
Amortization
Net
Gross
Accumulated
Amortization
Net
Intangible assets subject to amortization
     (Definite-lived)
 
 
 
 
 
 
Customer lists
$
1,818

$
(393
)
$
1,425

$
1,847

$
(330
)
$
1,517

Patents
519

(160
)
359

525

(127
)
398

Purchased and licensed technology
1,999

(1,129
)
870

1,929

(1,016
)
913

Trademarks
43

(17
)
26

57

(29
)
28

Other1
242

(106
)
136

206

(98
)
108

 
4,621

(1,805
)
2,816

4,564

(1,600
)
2,964

Intangible assets not subject to amortization
     (Indefinite-lived)
 
 
 
 
 
 
In-process research and development
43

—

43

62

—

62

Microbial cell factories2
306

—

306

306

—

306

Pioneer germplasm3
1,050

—

1,050

975

—

975

Trademarks/tradenames
881

—

881

819

—

819

 
2,280

—

2,280

2,162

—

2,162

Total
$
6,901

$
(1,805
)
$
5,096

$
6,726

$
(1,600
)
$
5,126


1. 
Primarily consists of sales and grower networks, marketing and manufacturing alliances and noncompetition agreements.
2. 
Microbial cell factories, derived from natural microbes, are used to sustainably produce enzymes, peptides and chemicals using natural metabolic processes. The company recognized the microbial cell factories as an intangible asset upon the acquisition of Danisco. This intangible asset is expected to contribute to cash flows beyond the foreseeable future and there are no legal, regulatory, contractual, or other factors which limit its useful life.
3. 
Pioneer germplasm is the pool of genetic source material and body of knowledge gained from the development and delivery stage of plant breeding. The company recognized germplasm as an intangible asset upon the acquisition of Pioneer. This intangible asset is expected to contribute to cash flows beyond the foreseeable future and there are no legal, regulatory, contractual, or other factors which limit its useful life.

The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $323, $312 and $253 for 2013, 2012 and 2011, respectively. The estimated aggregate pre-tax amortization expense from continuing operations for 2014, 2015, 2016, 2017 and 2018 is $371, $377, $339, $212 and $209, respectively, which are primarily reported in cost of goods sold.

us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock